Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Statement of Cash Flows [Abstract]      
Loss from continuing operations, net of taxes $ (4,302) $ (19,697) $ (19,138)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 2,766 2,660 2,606
Change in allowance for doubtful accounts 383 299 48
Non-cash interest expense 798 1,018 1,256
Stock-based compensation 2,011 2,655 3,362
Stock-based compensation for services rendered 520 323 398
Change in fair value of convertible note embedded derivative liability 1,008 7,559 (475)
Change in fair value of warrant liability 4,875 3,208 (147)
Loss on extinguishment of debt 431 1,785 293
Impairment of intangible assets 0 0 757
(Increase) / decrease in assets:      
Accounts receivable (6,040) (7,071) (3,882)
Deferred tax assets 556 (244) 148
Prepaid expenses and other current assets (430) (336) 104
Increase / (decrease) in liabilities:      
Accounts payable (4,983) 8,108 4,434
Accrued license fees and revenue share 7,973 5,221 (4)
Accrued compensation (525) 2,445 385
Other current liabilities (253) 52 (1,287)
Other non-current liabilities 182 (695) (116)
Net cash provided by / (used in) operating activities - continuing operations 4,970 7,290 (11,258)
Net cash provided by / (used in) operating activities - discontinued operations (3,701) (324) 4,594
Net cash provided by (used in) operating activities 1,269 6,966 (6,664)
Cash flows from investing activities      
Capital expenditures (2,314) (1,992) (1,418)
Proceeds from sale of cost method investment in Sift 0 0 999
Net cash used in investing activities - continuing operations (2,314) (1,992) (419)
Net cash used in investing activities - discontinued operations 0 (142) (177)
Net cash used in investing activities (2,314) (2,134) (596)
Cash flows from financing activities      
Cash received from issuance of convertible notes 0 0 16,000
Proceeds from short-term borrowings 0 2,500 0
Payment of debt issuance costs 0 (346) (2,383)
Options and warrants exercised 734 687 11
Repayment of debt obligations (1,650) (1,098) (11,000)
Net cash provided by / (used in) financing activities (916) 1,743 2,628
Effect of exchange rate changes on cash (31) (4) (119)
Net change in cash (1,992) 6,571 (4,751)
Cash and restricted cash, beginning of year 13,051 6,480 11,231
Cash and restricted cash, end of year 11,059 13,051 6,480
Supplemental disclosure of cash flow information      
Interest paid 383 1,071 1,406
Supplemental disclosure of non-cash financing activities      
Common stock of the Company issued for extinguishment of debt 10,582 14,632 0
Cashless exercise of warrants to purchase common stock of the Company $ 144 $ 10 $ 0